An international research team has developed a magnetic method to treat Parkinson's disease symptoms that could eventually replace surgical brain implants. Scientists injected magnetic nanoplatelets into the brains of mice with Parkinson's-like symptoms and used magnetic fields to improve their movement problems, achieving results comparable to conventional deep brain stimulation without permanently implanted electrodes.

How Does This Magnetic Treatment Work?

The technique works by harnessing the body's natural cellular machinery rather than sending electricity directly into the brain. When a magnetic field surrounds the brain, specially designed magnetic nanoparticles respond by producing tiny mechanical forces. These forces gently deform nearby cell membranes, similar to pressing a finger against an inflated balloon. That pressure opens mechanosensitive channels, allowing electrically charged ions to enter nerve cells and influence brain activity.

This approach differs fundamentally from traditional deep brain stimulation, which requires surgically implanted electrodes that establish a direct electrical connection to the brain. The magnetic method instead leverages neurons' natural mechanosensors to influence deep brain regions without permanent hardware.

"We use magnetic nanoparticles that we implant in the brain. They have a special shape and a magnetic structure. They were developed in order to transform magnetic fields into tiny mechanical forces," explained Prof. Dr. Danijela Gregurec from the Department of Chemistry and Pharmacy at Friedrich-Alexander-Universität Erlangen-Nürnberg.

Prof. Dr. Danijela Gregurec, Department of Chemistry and Pharmacy, Friedrich-Alexander-Universität Erlangen-Nürnberg

Why Is This Better Than Current Parkinson's Treatments?

Parkinson's disease gradually destroys brain cells that produce dopamine, a chemical messenger essential for controlling movement. As dopamine levels fall, motor circuits malfunction, causing tremors and other movement difficulties. Some patients receive a brain pacemaker, a small device placed beneath the collarbone that sends electrical signals to the subthalamic nucleus, a deep brain region. Stimulating this area can reduce movement symptoms, but the procedure is complex and not always successful.

The magnetic technique could eventually provide a less invasive option because it reaches deep brain regions without requiring electrodes to remain permanently implanted. Researchers from Friedrich-Alexander-Universität Erlangen-Nürnberg, RWTH Aachen, Maastricht University in the Netherlands, and KU Leuven in Belgium tested the method in animal models with damage to the same nerve cells affected in people with Parkinson's disease.

What Did the Research Show?

Using high-precision stereotactic procedures, researchers placed magnetic nanoparticles directly into the subthalamic nucleus, the same brain region targeted by conventional deep brain stimulation in Parkinson's patients. After the mice were exposed to a magnetic field, their movement deficits improved significantly. The effect was roughly equivalent to what researchers would have expected after implanting a brain pacemaker.

The magnetic particles remained in the animals' brains for several months without producing signs of inflammation, suggesting they were well tolerated during the test period. This safety profile is encouraging for potential future human applications.

Steps Toward Clinical Use

• Non-invasive delivery: Researchers are exploring ways to avoid injecting particles directly into the brain, with one possibility being administration through the bloodstream with particles designed to cross the blood-brain barrier.
• Wearable magnetic devices: Scientists are investigating compact wearable devices capable of generating the necessary magnetic fields, with a headband that patients could place on themselves being one possible design.
• Flexible parameter control: Adjusting the parameters of the magnetic field would allow researchers to control the nanoparticles more accurately than with traditional brain pacemakers.

"Nevertheless, we are convinced that the new method has enormous potential. It is not only considerably simpler and cheaper than a conventional brain pacemaker, it is probably also more flexible," stated Prof. Dr. Gregurec.

Prof. Dr. Danijela Gregurec, Department of Chemistry and Pharmacy, Friedrich-Alexander-Universität Erlangen-Nürnberg

While the approach is still several years away from potential clinical use in humans, the research opens new possibilities for treating Parkinson's disease and other movement disorders. The technique could also serve as a research tool for examining how tiny mechanical forces alter brain activity, potentially leading to insights that benefit other neurological conditions.

The findings were published in the journal Advanced Science in April 2026, representing a significant step forward in developing less invasive alternatives to current Parkinson's treatments.